ProTom International
ProTom International is a U.S. medical device manufacturer founded in 2008 that develops FDA 510(k)-cleared proton therapy systems (Radiance330 and Radiance330-c) using synchrotron and pencil beam scanning technology, selling to hospitals and cancer treatment centers globally via a Hong Kong-based exclusive Asian licensee.
- Company typePrivate
- Founded2008
- HeadquartersFlower Mound, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What ProTom International does
ProTom International Holding Corporation is a U.S.-based medical device manufacturer founded in 2008 that develops and commercializes proton therapy systems for cancer treatment. The company's product portfolio centers on the Radiance330 and Radiance330-c proton therapy systems, both of which have achieved full U.S. FDA 510(k) clearance. These systems are built on proprietary synchrotron-based proton acceleration technology combined with pencil beam scanning capability, designed to deliver precise tumor targeting while addressing the high cost and complexity traditionally associated with proton therapy installations.
The company generates revenue through two primary streams: capital sales of Radiance330 systems to hospitals and cancer treatment centers, and recurring long-term service and maintenance contracts that support debt service obligations. Pricing is not publicly disclosed, and the company employs an enterprise field sales motion targeting radiation oncology departments and dedicated cancer treatment facilities.
ProTom International operates a globally distributed commercial structure. Its wholly-owned subsidiary ProTom Asia Limited, headquartered in Tsuen Wan, Hong Kong, serves as the exclusive licensee covering China (including Hong Kong, Macau, and Taiwan), North Asia, South Asia, the Middle East, and Africa — with rights to manufacture, assemble, and test products in those territories. The company's U.S. headquarters is in Flower Mound, Texas. To date, ProTom has secured only "prestigious initial site installations," and its most recent disclosed funding was a $30 million round in April 2017.
ProTom International firmographics
Firmographics- Name
- ProTom International
- Legal name
- ProTom International Holding Corporation
- Website
- https://protominternational.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ProTom International is a U.S. medical device manufacturer founded in 2008 that develops FDA 510(k)-cleared proton therapy systems (Radiance330 and Radiance330-c) using synchrotron and pencil beam scanning technology, selling to hospitals and cancer treatment centers globally via a Hong Kong-based exclusive Asian licensee.
- Ownership category
- akta.pro rank
ProTom International industry classification
Industry- Product category
- Medical Radiation Therapy Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industry
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)
Keywords
Where ProTom International is headquartered
LocationHeadquarters
- HQ city
- Flower Mound
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
ProTom International business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Proton Therapy System Sales: Sale of Radiance330 proton therapy systems to hospitals and cancer treatment centers. The company has achieved FDA 510(k) clearance enabling commercial deployment.
- Long-term Service Contracts: Ongoing service and maintenance contracts that provide recurring revenue stream and ability to serve debt.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
ProTom International product offering
Product offeringCore offering
ProTom International designs, manufactures and sells proton therapy systems—principally the Radiance330 and the compact Radiance330-c—that use synchrotron-based proton acceleration and pencil beam scanning to deliver precision radiation therapy to cancer patients. The company supports its installed base with long-term service and maintenance contracts that generate recurring post-installation revenue.
Product overview
ProTom International Holding Corporation is a provider of cost-effective, commercially viable proton therapy systems. The company's product portfolio centers on the Radiance330 and Radiance330-c proton therapy systems, both of which have achieved full U.S. FDA 510(k) clearance. These systems utilize advanced technologies including Pencil Beam Scanning and Synchrotron Technology for precise tumor targeting in radiation therapy treatments.
Differentiator
Problem solved
Functional benefit
Brands
- Radiance330: Proton therapy system product line
- Radiance330-c
Products and services
- Radiance330 Proton Therapy System Proton therapy system providing cost-effective, commercially viable radiation treatment for cancer patients, with full U.S. FDA 510(k) clearance, proprietary synchrotron technology and pencil beam scanning for precise tumor targeting. Targeted at hospitals and cancer treatment centers.
- Radiance330-c Compact Proton Therapy System Compact variant of the Radiance proton therapy system designed for facilities with space constraints while maintaining clinical efficacy and full FDA 510(k) clearance. Targeted at hospitals and cancer treatment centers needing smaller-footprint proton therapy installations.
Companies that use ProTom International
Customer profileSegments1 record
Ideal customer profiles1 record
ProTom International technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ProTom International partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ProTom Asia LimitedcoreProTom Asia Limited is the exclusive licensee of ProTom International of USA for territories of China (including Hong Kong, Macau and Taiwan), North Asia, South Asia, the Middle East and Africa countries for all products, use of technologies, use of IP as well as manufacturing, assembly and testing of the products. This partnership enables regional manufacturing, sales, and service operations across the licensed territories.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
ProTom International competitors and assessment
Company assessmentDirect peers
- IBA (Ion Beam Applications): IBA is the global market leader in proton therapy systems, offering ProteusONE and ProteusPLUS solutions. It is the most direct competitor to ProTom's Radiance330 in the proton therapy equipment category, with overlapping customers (hospitals and cancer centers) and similar synchrotron/cyclotron-based technology approaches.
- Mevion Medical Systems: Mevion develops compact proton therapy systems (MEVION S250i with HYPERSCAN pencil beam scanning) targeting the same cost-conscious, space-constrained hospital segment that ProTom addresses with Radiance330-c. It is the closest direct competitor in the compact proton therapy sub-segment.
- Hitachi (Hitachi Particle Beam Therapy): Hitachi manufactures proton and carbon ion therapy systems installed globally, competing head-to-head with ProTom in hospital cancer center sales. Both companies target the same radiation oncology buyer with synchrotron-based particle therapy technology.
- Sumitomo Heavy Industries: Sumitomo Heavy Industries manufactures proton therapy systems, primarily for the Japanese market but also internationally. It competes with ProTom in the synchrotron-based proton therapy equipment category serving hospitals and cancer treatment centers.
Broad incumbents
- Varian Medical Systems (Siemens Healthineers): Varian, now part of Siemens Healthineers, is a dominant radiation oncology equipment provider offering linacs, proton therapy (ProBeam), and software solutions. It competes with ProTom in proton therapy while also serving the broader radiotherapy market that ProTom does not address.
- Elekta: Elekta is a leading provider of radiation therapy and radiosurgery equipment (Elekta Unity, Versa HD, Gamma Knife) and oncology software. It competes indirectly with ProTom by offering alternative advanced radiotherapy modalities that hospitals may choose over proton therapy.
Emerging players
- Accuray: Accuray develops the CyberKnife and TomoTherapy systems for precision radiation therapy, competing for hospital capital budgets that might otherwise fund proton therapy. It represents an alternative modality competing for the same oncology treatment share.
- ViewRay: ViewRay pioneered MR-guided radiation therapy with its MRIdian system, offering an alternative advanced modality that competes with proton therapy for hospital cancer center capital dollars. It overlaps with ProTom in targeting precision oncology treatment positioning.
Others
- Philips (Radiation Oncology Solutions): Philips provides radiation oncology treatment planning software and imaging solutions that integrate with proton therapy systems including those from ProTom. It is an adjacent ecosystem participant rather than a direct equipment competitor, but competes for hospital oncology capital budgets.
- GE HealthCare: GE HealthCare supplies diagnostic imaging, simulation, and oncology workflow software used alongside proton therapy installations. It is an adjacent ecosystem participant rather than a direct competitor, but addresses overlapping hospital oncology capital budgets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
ProTom International social profiles
Digital presenceProTom International compliance and trust
Trust signalCompliance1 record
ProTom International financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProTom International leadership team
Management profileNumber of profiles
Profiles6 records
ProTom International subsidiaries and ownership
Company hierarchySubsidiaries1 record
ProTom International funding detail
Funding detailFunding overview
Funding rounds3 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProTom International M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProTom International
What does ProTom International do?
ProTom International designs, manufactures and sells proton therapy systems—principally the Radiance330 and the compact Radiance330-c—that use synchrotron-based proton acceleration and pencil beam scanning to deliver precision radiation therapy to cancer patients. The company supports its installed base with long-term service and maintenance contracts that generate recurring post-installation revenue.
Is ProTom International a public or private company?
ProTom International is a private company. It is classified as unknown and is currently operating.
When was ProTom International founded?
ProTom International was founded in 2008. It employs 11 to 50 people.
Where is ProTom International based?
ProTom International is headquartered in Flower Mound, United States, in the North America region.
How does ProTom International make money?
Two revenue lines are on record. Proton Therapy System Sales are the primary driver. The others are long-term Service Contracts.
Who are ProTom International's main competitors?
Direct peers on record are IBA (Ion Beam Applications), Mevion Medical Systems, Hitachi (Hitachi Particle Beam Therapy) and Sumitomo Heavy Industries. Broad incumbents are Varian Medical Systems (Siemens Healthineers) and Elekta. Emerging players are Accuray and ViewRay. Others are Philips (Radiation Oncology Solutions) and GE HealthCare.
Does ProTom International have an API?
No public API is recorded for ProTom International.
What industry is ProTom International in?
ProTom International's product category is Medical Radiation Therapy Equipment. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 3844.